Today Heartbeam Inc., a Silicon Valley based medical device company, announced FDA 510(k) clearance of the HeartBeam system – the only cable-free, credit card-sized device that captures patient heart signals to provide comprehensive arrhythmia assessment.
HeartBeam’s system is a synthesized 12-lead ECG integrated with AI-based classification algorithms for heart attack detection, allowing physicians to detect non-life-threatening arrhythmias for patients in the clinic or at home. Physicians are able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility
Triple Ring is proud to have partnered with HeartBeam in the design and development of this cutting edge platform which redefines the future of cardiac health management. We congratulate HeartBeam on this critical milestone and look forward to more breakthroughs in the future.
